HS Connect | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

5,094 results for “HS Connect”

Trials

View all 4102 →

Connect for Cancer Prevention Study (Connect)

200,000 participants · First posted Oct 30, 2020

Neighborhood Connect

240 participants · First posted Aug 24, 2026

ACCU-CHEK Connect Personal Diabetes Management Study (PDM CONNECT)

122 participants · First posted Nov 9, 2015

Drugs

View all 187 →

HS-301

HS-10241

HS-10506

Organizations

View all 28 →

TAO Connect, Inc.

United States

Suzhou Connect Biopharmaceuticals Co., Ltd.

China

VORNA CONNECT (PTY) LTD

South Africa

News

View all 777 →

FDA Approves Bimzelx (bimekizumab-bkzx) for Moderate-to-Severe Hidradenitis Suppurativa

FDA Approves UCB's Bimzelx for Moderate-to-Severe Hidradenitis Suppurativa

FDA Approves Cosentyx for Pediatric Hidradenitis Suppurativa, Marking First IL-17A Inhibitor for Adolescents

Page 1 of 510